Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

5085 results about "Stem cell" patented technology

Stem cells are cells that can differentiate into other types of cells, and can also divide in self-renewal to produce more of the same type of stem cells. Telomerase is active in normal stem cells. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts in early embryonic development, and adult stem cells, which are found in various tissues of fully developed mammals. In adult organisms, stem cells and progenitor cells act as a repair system for the body, replenishing adult tissues. In a developing embryo, stem cells can differentiate into all the specialized cells—ectoderm, endoderm and mesoderm (see induced pluripotent stem cells)—but also maintain the normal turnover of regenerative organs, such as blood, skin, or intestinal tissues.

Serum-free medium mesenchymal stem cell inoculation device

A serum-free medium mesenchymal stem cell inoculation device, comprising a base, a rotating assembly, a center rod, a supporting rod, a clamping assembly, a test tube, a connecting tube, an arc-shaped air chamber, a fixing rack, a cooling tube and a collecting assembly, wherein the center rod is arranged at the top of the base through the rotating assembly, the supporting rod is annularly equally spaced on an outer wall of the top of the center rod along an axis of the center rod, the test tube is arranged at an end of the supporting rod away from the center rod through the clamping assembly, the connecting tube is arranged on the test tube, the fixing rack is arranged on an outer wall of the bottom of the center rod, the arc-shaped air chamber is in communication with the connecting tube through the cooling tube, and the collecting assembly is arranged on a side of the base. According to the inoculation device, by means of mutual cooperation of the rotating assembly, a moving assembly, the clamping assembly and the collecting assembly, operation errors caused by confusion of diluted test tubes and undiluted test tubes in a liquid adding and pipetting process of a worker are avoided, thereby improving the working efficiency of the worker.
Owner:NANJING DRUM TOWER HOSPITAL

Exosome-containing eye drops as well as preparation method and application thereof

The invention relates to eye drops containing exosomes and a preparation method and application thereof, and belongs to the technical field of eye drop preparation, the eye drops comprise exosome freeze-dried powder, the exosome freeze-dried powder is prepared from the exosomes obtained after mesenchymal stem cells are treated with TNF-alpha and IFN-alpha, and a herba houttuyniae extract, the eye drops provided by the invention can inhibit the phenotype of macrophage M1 and promote the M1 to be converted into the phenotype of M2; human corneal cell proliferation, migration and damage repair are promoted; mouse cornea injury repair is accelerated; the eye drops can be used for treating xerophthalmia, conjunctivitis and keratitis, and can also be used for preventing eye diseases and relieving asthenopia; the eye drops disclosed by the invention contain the exosome obtained after the mesenchymal stem cells are treated by the TNF-alpha and the IFN-alpha, so that the anti-inflammatory ability is stronger; the mesenchymal stem cell exosome and the herba houttuyniae extract are stored in a freeze-dried form, so that the activity is stable, and the storage time is long; in addition, the cordate houttuynia is cooperated with the exosome, so that the effect playing time can be prolonged, and the use frequency is reduced.
Owner:MIWAIMI (ZHANGJIAGANG) BIOTECHNOLOGY CO LTD +1

Bone organ constructed based on oxygen-releasing immune hydrogel microspheres and preparation method and application thereof

The invention relates to a bone organ constructed based on oxygen-releasing immune hydrogel microspheres and a preparation method and application thereof. An oxygen release material, macrophages and bone marrow mesenchymal stem cells are loaded in the oxygen release immune hydrogel microspheres. And adding the oxygen-releasing immune hydrogel microspheres into a culture medium for culturing to obtain the bone organ constructed based on the oxygen-releasing immune hydrogel microspheres. The oxygen release material (CaO2-HAp) is entrapped in the hydrogel microspheres, so that continuous oxygen supply can be provided in a defect area, the low-oxygen environment is improved, the activity of osteoblasts is improved, osteogenic differentiation is promoted, macrophages are entrapped by the microspheres, the immune microenvironment is regulated and controlled, the release of proinflammatory cytokines is reduced, the osteogenic efficiency is improved, and bone defect repair is accelerated. The micro-fluidic technology is utilized to accurately control the size and shape of the microspheres, so that the microspheres can adapt to irregular bone defects, bone organs are formed through long-term in-vitro culture, and the biological activity and adaptability of the bone repair material are improved.
Owner:SHANGHAI UNIV +1

Method for editing cattle gene based on Pro-iCHI

The invention belongs to the technical field of molecular biology and genetics, and particularly relates to a method for editing cattle genes based on Pro-iCHI. The invention provides a method for editing cattle genes based on Pro-iCHI, which comprises the following steps: transiently expressing protamine in cattle AG-haESCs after gene editing, and injecting into mature oocytes to obtain reconstructed embryos. The protamine can remove abnormal DNA methylation generated by an oocyte cytoplasm injection haploid stem cell technology, cell nucleuses are compressed into a sperm-like structure, the obtained bovine Pro-iCHI embryo can smoothly develop into a blastocyst, and the ratio of the blastocyst to the blastocyst obtained by in-vitro fertilization is equivalent. Moreover, the protamine coding gene is inserted into the saccharomyces cerevisiae protein expression vector and then is subjected to transient expression, so that the protamine coding gene cannot be integrated into a genome to cause insertion of an exogenous gene while abnormal DNA methylation is erased.
Owner:INNER MONGOLIA UNIVERSITY

Adipose-derived stem cell composition for wound repair as well as preparation method and application of adipose-derived stem cell composition

The invention provides an adipose-derived stem cell composition for wound repair as well as a preparation method and application thereof, and belongs to the technical field of stem cells. The method comprises the following steps: adding fetal calf serum, dexamethasone, penicillin, streptomycin, collagen, magnetic particles and a P substance into a DMEM culture medium to prepare a culture medium, performing low-frequency magnetic field culture and separation on adipose-derived stem cells to obtain a stem cell solution, performing embedding to obtain stem cell microspheres, freeze-drying supernate to obtain a paracrine culture substance, and performing freeze-drying on the paracrine culture substance to obtain the adipose-derived stem cells. The adipose-derived stem cell composition for wound repair is prepared by mixing the adipose-derived stem cell with stem cell microspheres, hydroxypropyl methyl cellulose, carboxymethyl chitosan, hyaluronic acid, glycerol and stem cell microspheres, has better effects of implanting into damaged tissues, releasing nutrient substances, promoting neovascularization, regulating oxidative stress and inducing anti-inflammatory response, is beneficial to wound repair, and has a good application prospect. The gel can be converted into a gel phase at the skin epidermis temperature of 35-37 DEG C, components are stabilized, and sustained and controlled release is realized.
Owner:BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD

Mitochondria-targeted antioxidant hybrid vesicle as well as preparation method and application thereof

The invention provides a preparation method of mitochondria-targeted antioxidant hybrid vesicles. The preparation method comprises the following steps: S1, preparing and separating adipose-derived stem cell nano-vesicles; s2, preparing a liposome loaded with dihydromyricetin and distearoyl phosphatidyl ethanolamine-polyethylene glycol 2000-triphenylphosphine targeting peptide by an ethanol injection method; and S3, preparing the hybrid nano vesicles loaded with the dihydromyricetin and the distearoyl phosphatidyl ethanolamine-polyethylene glycol 2000-triphenylphosphine targeting peptide. The invention also provides the hybrid vesicles prepared by the method and application of the hybrid vesicles in preparation of refractory diabetes wound treatment drugs. The lipidosome and the adipose-derived stem cell nano-vesicles are hybridized to prepare the hybridized vesicles capable of targeting mitochondria and resisting oxidation, the hybridized vesicles are applied to wound treatment for the first time, the problem of oxidative stress of diabetic wounds is solved, wound healing is accelerated, and a new strategy is provided for optimizing mitochondrial function defects and oxidative stress of the diabetic wounds.
Owner:XIEHE HOSPITAL ATTACHED TO TONGJI MEDICAL COLLEGE HUAZHONG SCI & TECH UNIV

Atomizing agent containing stem cell exosome as well as preparation method and application of atomizing agent

The invention provides an atomizing agent containing stem cell exosomes as well as a preparation method and application of the atomizing agent, and belongs to the technical field of exosomes. Ferroferric oxide magnetic particles are prepared, the surfaces of the ferroferric oxide magnetic particles are modified through tannic acid, berberine and adriamycin are loaded, then the ferroferric oxide magnetic particles and the exosome secreted by adipose-derived mesenchymal stem cells are mixed, incubated and centrifuged, the mixture is added into normal saline, uniform ultrasonic dispersion is conducted, and the atomizing agent containing the stem cell exosome is prepared. The prepared atomizing agent containing the stem cell exosome is simple in preparation method and wide in raw material source, the prepared atomizing agent directly enters the lung through spray administration, the unique performance of magnetic targeting drug delivery is achieved, drugs are released in a targeted and fixed-point mode, the drug effect is improved, and the effects of efficiently promoting tumor cell apoptosis and resisting lung cancer and pneumonia are achieved.
Owner:BEIJING SINOMENIUM STEM CELL TECH RES INST CO LTD

Carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops as well as preparation method and application thereof

The invention discloses carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops as well as a preparation method and application thereof, and relates to the technical field of eye drops and medical biogel. The carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops are prepared from tannic acid modified carboxymethyl chitosan and adipose tissue-derived stromal cell exosome freeze-dried powder, the carboxymethyl chitosan-hyaluronic acid-stem cell exosome eye drops provided by the invention can effectively treat xerophthalmia, and are stable in components, safe and reliable. The three components including the tannic acid modified carboxymethyl chitosan, the hyaluronic acid and the adipose tissue-derived stromal cell exosome coexist, so that the functions of all the components can be fully played, a synergistic effect is achieved, and a better treatment effect on xerophthalmia is achieved.
Owner:BIOLOGY INST OF SHANDONG ACAD OF SCI

3D bio-printing osteochondral organ based on dynamic mechanical regulation and control as well as construction method and application of 3D bio-printing osteochondral organ

The invention provides a 3D biological printing osteochondral organ based on dynamic mechanical regulation and control, and a construction method and application thereof. Compared with the prior art, the invention innovatively provides a biphasic scaffold optimization modification strategy: firstly, an osteochondral hydrogel scaffold with an accurate layered structure is prepared by adopting a 3D biological printing technology, then a cell mechanical transduction signal channel is activated by a dynamic pressure stimulation system, and cartilage / bone biphasic differentiation of stem cells is directionally regulated and controlled; and by constructing a bionic mechanical microenvironment, the obtained osteochondral organ not only keeps excellent biocompatibility, but also has gradient mechanical properties and a clear spatial layered structure (cartilage layer-bone layer), the directional cartilage formation / osteogenic differentiation efficiency of the osteochondral organ is remarkably improved, and the osteochondral organ has a good application prospect. The problems of spatial heterogeneity construction and accurate regulation and control of cell fate in osteochondral tissue engineering are effectively solved, and the method has important application value in the fields of osteochondral defect repair treatment and mechanical stimulation mechanism research.
Owner:JILIN UNIVERSITY

Bionic matrix hydrogel for constructing bone organs and preparation method thereof

The invention relates to bionic matrix hydrogel for constructing bone organs and a preparation method of the bionic matrix hydrogel. The bionic matrix hydrogel is prepared from a bone acellular extracellular matrix, a salmon DNA (Deoxyribose Nucleic Acid) network and a calcium phosphate oligomer under the combination of photo-crosslinking and self-assembly physical crosslinking. The acellular extracellular matrix in the bionic matrix hydrogel can simulate organic components in natural bones, the calcium phosphate oligomer can simulate inorganic components in the natural bones, and sufficient phosphate ions can be provided for biomineralization due to introduction of a DNA network. The biomimetic matrix hydrogel can replace Matrigel to act in bone organoid culture, provide a living environment similar to bone tissue for three-dimensional culture cells, enhance substance exchange and signal transduction between cells, promote proliferation, adhesion and osteogenic differentiation of bone marrow mesenchymal stem cells, and further accelerate the process of biomineralization. The invention provides an optional new material for preparing the functional bone organ.
Owner:SHANGHAI UNIV

Stem cell exosome vesicles induced by traditional Chinese medicine functional components as well as preparation method and application of stem cell exosome vesicles

PendingCN120424865AMetabolism disorderCulture processBeta-cell FunctionIslet cells
The invention provides a stem cell exosome vesicle induced by traditional Chinese medicine functional components as well as a preparation method and application thereof, and belongs to the technical field of biological medicines. According to the preparation method of the stem cell exosome vesicle, traditional Chinese medicine functional components serve as an exosome inducer, stem cells can be induced to proliferate and secrete exosome with the enhanced function, the yield of the exosome can be increased, bioactive molecules can be loaded, and the bioavailability of the exosome in diabetes treatment is remarkably improved. The stem cell exosome vesicle disclosed by the invention can be applied to treatment of diabetes and complications thereof, not only can improve functions of islet cells, but also can treat chronic inflammation, microangiopathy and other metabolic diseases related to diabetes, and has a wide clinical application prospect.
Owner:北京圣美细胞生命科学工程研究院有限公司

Exosome, mesenchymal stem cell and application of exosome and mesenchymal stem cell in treatment of type 2 diabetes mellitus

The invention provides an exosome, a mesenchymal stem cell and application of the exosome and the mesenchymal stem cell in treatment of type 2 diabetes mellitus, and belongs to the technical field of biological medicine. The exosome secreted by the umbilical cord mesenchymal stem cells of the composite pretreatment group is used for treating the type 2 diabetes mellitus, and the obvious advantages are shown. Compared with a model control group, the exosome has the advantages that the glucose tolerance of diabetic rats treated by the exosome is obviously improved, the blood glucose value is reduced by about 47.5% within 120 minutes, the area under a blood glucose curve (AUC) is reduced by about 50.5%, the serum insulin is increased by about 147.7%, insulin secretion is effectively promoted, the glycosylated hemoglobin level is obviously reduced, and the long-term blood glucose control effect is good. By integrating various indexes, the exosome obtained by the composite pretreatment scheme provided by the invention has a remarkable effect of improving the illness state of rats with type 2 diabetes mellitus, provides a new effective strategy for treatment of type 2 diabetes mellitus, and shows a good application prospect.
Owner:WEST CHINA HOSPITAL SICHUAN UNIV +1

Phytobacterium plantarum and application thereof in improving intestinal inflammation and repairing intestinal mucosa injury

The invention relates to the technical field of functional microorganism screening and application, and particularly provides a strain of lactobacillus plantarum and an application of the lactobacillus plantarum in improvement of intestinal inflammation and repair of intestinal mucosa injury. The plant lactobacillus is preserved in the China General Microbiological Culture Collection Center (CGMCC for short) on August 1, 2024, the address is No.3, No.1 Yard, Beichen West Road, Chaoyang District, Beijing, and the preservation number of the plant lactobacillus is CGMCC No.31521. The strain has remarkable antioxidant, bacteriostatic and anti-inflammatory effects, can repair intestinal barrier injury of mice with colitis, promote renewal of intestinal stem cells, promote growth of intestinal beneficial bacteria and inhibit proliferation of harmful bacteria, can be widely applied to prevention and treatment of enteritis, and has a wide market prospect.
Owner:SHENYANG AGRI UNIV

Umbilical cord mesenchymal stem cell for treating myocardial infarction as well as preparation method and application of umbilical cord mesenchymal stem cell

ActiveCN119019494AImprove the effectiveness of treating myocardial infarctionextended dwell timeUnknown materialsPharmaceutical non-active ingredientsUmbilical cordTransmembrane protein
The invention belongs to the technical field of biological medicines, and particularly relates to umbilical cord mesenchymal stem cells as well as a preparation method and application thereof in treating myocardial infarction. The invention provides an umbilical cord mesenchymal stem cell, the umbilical cord mesenchymal stem cell secretes a specific exosome, the exosome comprises a fusion protein, and the fusion protein is formed by fusing a peptide targeting ischemic myocardial tissue and an exosome transmembrane protein CD9 and anchored on the surface of the exosome. Therefore, the exosome secreted by the umbilical cord mesenchymal stem cells has higher targeting property and activity. The invention also provides a preparation method of the umbilical cord mesenchymal stem cells, and further, the umbilical cord mesenchymal stem cells prepared by the invention are used for preparing medicines which are applied to treatment of myocardial infarction.
Owner:广州飞来爱生命科技有限公司

Serum-free culture medium for in-vitro suspension culture of porcine muscle stem cells and application of serum-free culture medium

The invention provides a serum-free culture medium for in-vitro suspension culture of porcine muscle stem cells and application of the serum-free culture medium. The serum-free culture medium can help the porcine muscle stem cells to be subjected to suspension enlarged culture under serum-free and carrier-free conditions. Compared with a traditional porcine muscle stem cell culture scheme and culture medium, the serum-free suspension culture medium has the advantages that high-density continuous culture of porcine muscle stem cells can be realized in a batch culture process and a fed-batch culture process under the serum-free carrier-free suspension culture condition, high cell viability is maintained, and the survival rate of the porcine muscle stem cells is increased. The peak density of the cells reaches 1 * 10 < 7 > cells / mL or above, and the cell viability is maintained to be 90% or above. The method has the beneficial effects that the problem of serum-free carrier-free efficient suspension amplification of the seed cells of the cell culture meat is effectively solved, and a technical and raw material basis is provided for industrial production of the cell culture meat.
Owner:NANJING JOES FUTURE FOOD TECH CO LTD

Stem cell exosome composition for treating erectile dysfunction and application thereof

The invention provides a stem cell exosome composition for treating erectile dysfunction and application thereof, the stem cell exosome composition comprises stem cell exosome and vasoactive intestinal peptide, and the amino acid sequence of the vasoactive intestinal peptide is shown as SEQ ID NO: 2. The amino acid structure of the vasoactive intestinal peptide is modified, so that the biological stability can be improved; the vasoactive intestinal peptide is combined with the adipose-derived mesenchymal stem cell exosome for use, so that the ED symptom can be relieved; the vasoactive intestinal peptide and the adipose tissue-derived stem cell exosome are combined for use, so that the expression level of cell factors can be adjusted, and the microenvironment of penis tissues can be improved.
Owner:SANYA PRIVATE HEALTH HOSPITAL CO LTD

High-activity product obtained based on cornu cervi pantotrichum stem cells, preparation method and application thereof

The invention provides a high-activity product obtained based on cornu cervi pantotrichum stem cells as well as a preparation method and application thereof. The preparation method comprises the following steps: preparing a serum-free culture medium, unfreezing immortalized cornu cervi pantotrichum stem cells, centrifuging, performing inoculated culture, performing passage, and finally performing resuspension and freeze-drying by using water for injection to obtain freeze-dried powder. The culture medium is composed of a basic culture medium and a growth additive, and all the components are described in detail. The method can efficiently enrich the specific active product of the cornu cervi pantotrichum wax sheet. The invention further relates to application of the high-activity product obtained based on the cornu cervi pantotrichum stem cells in skin care products (such as water aqua and emulsion) and health care products (such as nutritional supplements and functional drinks), provides a new way for development of related products, and has potential economic and social values.
Owner:HANGZHOU JIMI BIOTECHNOLOGY CO LTD

Pig chimeric embryo culture medium and application thereof in effectively improving in-vitro chimeric ability of pig embryonic stem cells

ActiveCN119351317AIncreased proliferationStrong differentiation abilityGenetically modified cellsCulture processBiotechnologyPorcine embryos
The invention discloses a pig chimeric embryo culture medium and application thereof in effectively improving the in-vitro chimeric ability of pig embryonic stem cells, and belongs to the technical field of bioengineering. According to the pig chimeric embryo culture medium disclosed by the invention, a neutral culture environment for promoting synchronous development of stem cells and embryos is created by accurately regulating and controlling growth factors, nutrient substances and other key components in the culture medium. On the basis, overexpression of anti-apoptosis factors, optimization of microinjection conditions and adoption of a laser-assisted incubation means are combined, so that the chimeric efficiency is further improved, integration of the stem cells and embryos is effectively supported, the chimeric efficiency is improved, and a reliable in-vitro tool is provided for evaluating the chimeric ability and pluripotency of the pig stem cells.
Owner:HUAZHONG AGRI UNIV

Polypeptide for promoting proliferation of human umbilical cord mesenchymal stem cells and application of polypeptide in in-vitro culture of human umbilical cord mesenchymal stem cells

The invention discloses a polypeptide for promoting proliferation of human umbilical cord mesenchymal stem cells and application of the polypeptide in in-vitro culture of the human umbilical cord mesenchymal stem cells. The mesenchymal stem cells have all characteristics of stem cells, have self-renewal and multidirectional differentiation potentials, and can be differentiated into various mesenchymal tissues, such as bones, cartilages, fat and the like. How to rapidly proliferate the human umbilical cord mesenchymal stem cells in vitro so as to rapidly obtain enough seed cells in a short time has important significance. The invention provides a polypeptide with a sequence as shown in Sequence NO.1. The polypeptide has an obvious effect of promoting in-vitro proliferation of human umbilical cord mesenchymal stem cells, does not change phenotypes of the human umbilical cord mesenchymal stem cells, and can be used for in-vitro efficient amplification of the human umbilical cord mesenchymal stem cells.
Owner:JIANGSU QICHUANG CELL GENE ENGINEERING RESEARCH INSTITUTE CO LTD

Application of umbilical cord mesenchymal stem cell exosome in preparation of medicine for treating male infertility caused by hidden testis

PendingCN120549976ACell dissociation methodsSkeletal/connective tissue cellsSeminiferous tubuleMouse Testicle
The invention relates to the technical field of biological medicines, in particular to an umbilical cord mesenchymal stem cell exosome and application of the umbilical cord mesenchymal stem cell exosome in preparation of a medicine for treating male infertility caused by hidden testis. The prepared high-concentration umbilical cord mesenchymal stem cell exosome suspension preparation is directly used for treating cultured spermatogonial cells and spermatoblasts in vitro, is injected into the testis of a mouse, and is used for improving the seminiferous tubule and spermatogenic microenvironment of testis tissue and promoting division and proliferation of the spermatogonial cells and the spermatoblasts. The method can effectively reverse oligospermia and azoospermia caused by the hidden testis, and compared with a model without intervention of treatment means, the method can effectively promote increase and even regeneration of sperms in the testis.
Owner:FUJIAN MATERNAL & CHILD HEALTH HOSPITAL

Human placenta-derived angiogenic stem cells (hPASCs) and application thereof

The invention provides human placenta-derived vasogenic stem cells (hPASCs) and application thereof. The human placenta-derived angiogenic stem cells (hPASCs) disclosed by the invention are preserved in China Center for Type Culture Collection, Wuhan University, Wuhan, China; the preservation date is April 2, 2025; the preservation number of the strain is CCTCC (China Center For Type Culture Collection) NO: The hPASCs disclosed by the invention contain angiogenic cell subgroups, have stem cell stemness, have an angiogenesis effect in vivo and in vitro, and can be used for treatment of diseases such as cardiovascular diseases and vascularization construction of artificial organs and tissues.
Owner:WENZHOU MEDICAL UNIV

Preparation method of anti-aging cosmetic containing exosome

The invention discloses a preparation method of an anti-aging cosmetic containing exosome, and relates to the technical field of cosmetic preparation, the cosmetic is prepared from the following components in percentage by mass: 1.01%-5.05% of exosome wrapped by liposome, 0.5%-3% of an antioxidant, 1%-3% of a centella asiatica extract, 1%-3% of a rhodiola rosea extract, 10%-15% of a humectant and the balance of a basic matrix; wherein the exosome wrapped by the liposome is a mixture formed by mixing an exosome secreted by adipose-derived mesenchymal stem cells and an exosome secreted by plant cells according to a mass ratio of 1.5: 1.2; the plant is ginseng. According to the skin care product, the antioxidant, the centella asiatica extract and the exosome act together to improve the DPPH clearance rate of the skin care product, the skin brightness is improved, the roughness is reduced, and the excellent anti-aging performance is achieved. The lipid exosome-antioxidant-centella asiatica ternary system disclosed by the invention has a multi-target synergistic effect.
Owner:CARSON (JILIN) CELL RESOURCE LIBRARY MANAGEMENT CO LTD

Construction method and application of genetically modified mesenchymal stem cells

The invention discloses a construction method and application of a gene modified mesenchymal stem cell. The construction method comprises the following steps: constructing a recombinant lentivirus carrying PD-L1 and ICAM1 genes; the recombinant lentivirus carrying the PD-L1 gene and the ICAM1 gene is transfected with mesenchymal stem cells, and the mesenchymal stem cells are screened by puromycin, so that an engineered mesenchymal stem cell strain modified by the PD-L1 gene and the ICAM1 gene is obtained; the mesenchymal stem cells provided by the invention are modified by engineering genes of PD-L1 and ICAM1, and are screened by puromycin to obtain a mesenchymal stem cell strain capable of stably and highly expressing the genes of PD-L1 and ICAM1; after the mesenchymal stem cells highly expressing the PD-L1 and ICAM1 genes are intravenously injected into an autoimmune hepatitis animal model, the autoimmune hepatitis symptom can be remarkably relieved, the liver injury degree can be reduced, the expression of inflammatory factors can be regulated, the inflammatory reaction can be inhibited, and the obvious curative effect can be achieved.
Owner:XIAN CHAOYUE STEM CELL TECH CO LTD

Differentiation of pancreatic endocrine cells

Disclosed herein are compositions and methods related to differentiation of stem cells into pancreatic endocrine cells. In some aspects, the methods provided herein relate to generation of pancreatic β cell, α cell, δ cells, and EC cells in vitro. In some aspects, the disclosure provides pharmaceutical compositions including the cells generated according to the methods disclosed herein, as well as methods of treatment making use thereof.
Owner:VERTEX PHARMACEUTICALS INC

Co-differentiated vascularized liver organ and construction method thereof

The invention belongs to the technical field of organoid culture, and particularly relates to a co-differentiated vascularized liver organoid and a construction method thereof. Aiming at the problems that the existing liver organ vascularization mostly adopts a co-culture mode, the operation process is complicated, the cell source heterogeneity is relatively high, the randomness is strong, the uniformity is poor and the like, the invention provides the construction method of the co-differentiated vascularized liver organ. The preparation method comprises the following steps: sequentially inducing and culturing directional endoderm cells, posterior preintestinal cells and hepatic endoderm cells, adding an S1 culture medium containing VEGF to induce and culture for 1-3 days, then adding an S2 culture medium containing VEGF, BMP4 and FGF2 to induce and culture for 3-5 days, and then adding an S3 culture medium containing VEGF to induce and culture for 14-20 days to obtain the co-differentiated vascularized liver organ. According to the method disclosed by the invention, the operation process is simplified, the experiment efficiency is improved, the liver organ which is rich in blood vessel network, high in maturity and of a blood vessel-bile duct structure is obtained, and a foundation is laid for large-scale production and clinical application.
Owner:SICHUAN UNIV

DNA-silk fibroin composite hydrogel microsphere and preparation method therefor

The present invention relates to the field of biomedical materials. Particularly provided is a DNA-silk fibroin composite hydrogel microsphere. The DNA-silk fibroin composite hydrogel microsphere is prepared from DNA and silk fibroin on the basis of the micro-fluidic technology by means of combination of self-assembly physical crosslinking and photo-crosslinking. The introduction of a silk fibroin network into the composite hydrogel microsphere can provide mechanical performance for a DNA hydrogel network and reduce the production cost. RGD can remarkably improve the cell loading capability of the microsphere. The hydrogel microsphere can simulate a microenvironment of cartilage tissue by means of three-dimensional loading of high-density cells, so as to enhance substance exchange and signaling between cells, and more effectively promote the proliferation and adhesion of bone marrow mesenchymal stem cells and regulating the chondrogenic differentiation, thus promoting cartilage regeneration and repair, and providing an available material for preparing medicaments or medical instruments for cartilage defect repair.
Owner:SHANGHAI UNIV +1

Bone organ model and construction method and application thereof

The invention provides a bone organ model as well as a construction method and application thereof, and the method comprises the following steps: arranging a biological material with a micropore array in a cell culture plate to obtain a bone organ chip; suspending the initial stem cells in a culture medium, and promoting the cells to form a spherical structure through cell aggregation or by using a non-adhesive culture surface, so as to obtain cell spheres; and culturing the cell spheres in the bone organ chip by adopting the culture medium for constructing the bone organ model to obtain the bone organ model. The skeletal organ is successfully constructed through in-vitro self-organized 3D co-culture initial stem cells including embryonic stem cells, induced pluripotent stem cells, bone marrow mesenchymal stem cells, osteoblasts, bone cells, all levels of osteogenic precursor cells, osteogenic-like cells and MC3T3-E1 cells, and the skeletal organ can become an important tool for researching and treating bone related diseases.
Owner:RENMIN HOSPITAL OF WUHAN UNIVERSITY (HUBEI GENERAL HOSPITAL)

Method for inducing porcine embryonic stem cells to differentiate skeletal muscle cells by using complete small molecule compound

The invention belongs to the field of stem cells, and particularly relates to a method for inducing porcine embryonic stem cells to differentiate skeletal muscle cells by using a complete small molecule compound. The method comprises the following steps: S1, an induction stage: culturing the porcine embryonic stem cells in a culture medium for two days, and replacing with culture medium culture in the induction stage; s2, a differentiation stage: a differentiation stage culture medium is used for culture. The method is simple in operation process and high in efficiency, and large-scale production of the cell meat is facilitated while differentiation of the porcine embryonic stem cells into the skeletal muscle cells is achieved.
Owner:BEIJING SINOGENE BIOTECHNOLOGY CO LTD